Evaluation of two VIDAS® prototypes for detecting anti-HEV IgG

Highlights • High performance anti-hepatitis E virus (HEV) IgG assays are crucial for epidemiology. • The sensitivity of both prototypes is >95%, similar to the Wantai anti-HEV IgG assay. • Both VIDAS® prototypes appear to be suitable for routine detection of anti-HEV IgG.

Saved in:
Bibliographic Details
Published inJournal of clinical virology Vol. 89; pp. 46 - 50
Main Authors Abravanel, Florence, Goutagny, Nadège, Perret, Corinne, Lhomme, Sébastien, Vischi, Françoise, Aversenq, Alexandre, Chapel, Aude, Dehainault, Nathalie, Piga, Nadia, Dupret-Carruel, Jacqueline, Izopet, Jacques
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.04.2017
Subjects
Allergy and Immunology
Anti-HEV IgG
Automation, Laboratory - methods
Hepatitis Antibodies - blood
Hepatitis E - diagnosis
Hepatitis E Virus
Humans
Immunoassay - methods
Immunoglobulin G - blood
Infectious Disease
Prototypes
Sensitivity and Specificity
VIDAS
Hepatitis E Virus
VIDAS
Prototypes
Anti-HEV IgG
Online AccessGet full text

Cover

More Information
Summary:Highlights • High performance anti-hepatitis E virus (HEV) IgG assays are crucial for epidemiology. • The sensitivity of both prototypes is >95%, similar to the Wantai anti-HEV IgG assay. • Both VIDAS® prototypes appear to be suitable for routine detection of anti-HEV IgG.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1386-6532
1873-5967
DOI:10.1016/j.jcv.2017.02.009